Valiant Laboratories P/E Ratio
Valiant Laboratories (VALIANTLAB) P/E ratio is not applicable — EPS (TTM) ₹-0.51. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company reported a loss in the most recent quarter. P/E ratio is not meaningful for loss-making periods.
Current EPS: ₹-0.51
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Mar 2026 | 0.32 | 2 | Profit |
| Sept 2025 | 0.04 | 0 | Profit |
| Mar 2025 | 0.16 | 1 | Profit |
| Jun 2025 | 0.42 | 2 | Profit |
| Dec 2025 | -1.30 | -7 | Loss |
| Sept 2024 | -1.09 | -5 | Loss |
| Mar 2024 | -0.33 | -1 | Loss |
| Jun 2024 | -0.13 | -1 | Loss |
Healthcare Peers with Valid P/E Ratios — VALIANTLAB Comparison
Healthcare sector average P/E 55.31, median 31.4 — VALIANTLAB excluded (negative EPS).
Sector Average PE
55.31
Sector Median PE
31.4
Lowest PE
2.86
Profitable Companies
195
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Sunrest Lifescience | SUNREST | 3.65 | ₹29 | Low |
| Phaarmasia | PHRMASI | 3.84 | ₹68 | Low |
| JFL Life Sciences | JFLLIFE | 4.64 | ₹59 | Low |
| Sun Pharma Advanced Rese… | SPARC | 5.0 | ₹8,492 | Low |
| Shelter Pharma | SHELTER | 5.32 | ₹50 | Low |
| Mono Pharmacare | MONOPHARMA | 6.02 | ₹19 | Low |
| Royal Sense | ROYAL | 7.4 | ₹51 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹79 | Low |
| Amwill Health Care | AMWILL | 7.71 | ₹88 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see Valiant Laboratories share price chart.
- Read VALIANTLAB dividend growth for the complete payout history and dividend yield track record.
- See VALIANTLAB price book multiple to compare market price against book value per share.